The International Society for the Study of Vulvovaginal Disease (ISSVD) is delighted to announce Tanja Bohl, MD as its new president. Dr. Bohl is a dermatologist and clinical lead at Jean Hailes for Women's Health in Melbourne, Australia. Dr. Bohl is a leading authority on vulvovaginal health and a passionate advocate for women's health. She has dedicated her career to improving the lives of women through education, research, and clinical care. We congratulate her on this well-deserved honor and wish her all the best in her new role. She will serve as President until the close of the XXVII World Congress to be held in Ljubljana, Slovenia, September 13-18, 2024.
Understanding how the microorganisms that inhabit the vagina interact with each other and with the host is fundamental in the diagnosis, treatment, and prevention of vulvovaginal disease. The ISSVD is proud to announce the publication of 5 comprehensive manuscripts that revealed advances on the role of the microbiota in lower genital tract infection in women of all ages. These manuscripts are preceded by a commentary by Prof. Jack Sobel, Dean and Distinguished Professor of the Wayne State University School of Medicine
The ISSVD Vaginitis and Microbiome Committeesubcommitteeon Microscopy guidelines has published a manuscript titled:
The ISSVD Vaginitis and Microbiome Committee subcommittee on vaginal atrophy has published a manuscript titled:
The ISSVD Vaginitis and Microbiome Committee subcommittee on vaginal atrophy has published a manuscript titled:
ISSVD and ICS comments on the FDA communication on use of laser and radiofrequency for vaginal ‘rejuvenation’, vaginal cosmetic procedures, urinary incontinence, lichen sclerosus, and vulvodynia.